Global X Genomics & Biotechnology ETF Rating $8.20 +0.13 (+1.61%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$8.18 -0.01 (-0.18%) As of 05/2/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.67Holdings in GNOM have an aggregate rating of Moderate Buy based on 503 analyst ratings issued in the past year covering 38 companies (96.2% of the portfolio).GNOM Aggregate Price Target$8.20High Prediction$8.20Average Prediction$8.20Low Prediction$8.20Holdings in GNOM have an aggregate price target of $8.20 and a range of $8.20 to $8.20 covering 38 companies (96.2% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.93%NTRANatera$156.66+3.5%2.8931 of 5 stars3.00$175.76 12.2%16Upcoming EarningsInsider Trade5.22%QGENQiagen$43.15+2.3%3.8188 of 5 stars2.30$48.42 12.2%10Upcoming Earnings5.13%VCYTVeracyte$30.35+2.2%4.1299 of 5 stars2.70$42.60 40.4%10Upcoming EarningsShort Interest ↑High Trading Volume4.97%BNTXBioNTech$104.94+2.5%2.6238 of 5 stars2.89$143.44 36.7%18Upcoming EarningsPositive News4.80%BMRNBioMarin Pharmaceutical$62.03-1.1%4.9219 of 5 stars2.70$92.95 49.9%23Analyst ForecastAnalyst RevisionNews CoverageGap Up4.63%ALNYAlnylam Pharmaceuticals$259.39+1.7%4.216 of 5 stars2.77$319.17 23.0%26Earnings ReportAnalyst DowngradeNews Coverage4.31%CRSPCRISPR Therapeutics$38.25+1.4%3.0057 of 5 stars2.48$73.11 91.1%21Upcoming Earnings4.29%AAgilent Technologies$108.68+2.1%4.7544 of 5 stars2.46$143.00 31.6%13Positive NewsGap Up4.16%LEGNLegend Biotech$33.17-2.3%2.7162 of 5 stars2.92$78.82 137.6%12Positive News3.86%TECHBio-Techne$50.49+1.7%4.8911 of 5 stars2.38$81.14 60.7%83.76%RNAAvidity Biosciences$32.20-1.5%2.7117 of 5 stars3.00$66.69 107.1%13Upcoming EarningsInsider TradePositive News3.69%RAREUltragenyx Pharmaceutical$39.30+0.8%4.3727 of 5 stars2.93$92.79 136.1%14Upcoming EarningsShort Interest ↑Positive News3.59%ARWRArrowhead Pharmaceuticals$14.42+2.7%3.6239 of 5 stars2.60$41.44 187.4%10Upcoming EarningsPositive News3.55%BEAMBeam Therapeutics$20.24+2.1%3.2489 of 5 stars3.00$49.45 144.3%14Upcoming EarningsShort Interest ↑News Coverage3.17%GILDGilead Sciences$103.68+0.4%4.7892 of 5 stars2.78$110.55 6.6%27Dividend Announcement2.86%ILMNIllumina$77.88+1.8%4.6568 of 5 stars2.48$137.55 76.6%21Upcoming EarningsAnalyst ForecastNews CoveragePositive News2.84%VRTXVertex Pharmaceuticals$501.15+0.5%3.9695 of 5 stars2.64$514.91 2.7%25Upcoming EarningsPositive News2.76%MRNAModerna$27.61+2.1%4.3397 of 5 stars2.04$53.95 95.4%23Earnings ReportAnalyst ForecastNews CoverageGap Up2.48%SRPTSarepta Therapeutics$63.51+1.2%4.7181 of 5 stars2.83$157.95 148.7%23Upcoming Earnings2.25%CDNACareDx$15.00-0.5%3.6659 of 5 stars2.57$30.33 102.2%7Earnings ReportInsider TradePositive News2.09%TXG10x Genomics$8.43+4.1%4.6798 of 5 stars2.38$18.85 123.6%16News Coverage2.05%NTLAIntellia Therapeutics$8.84+2.3%4.6648 of 5 stars2.65$36.68 315.0%20Upcoming EarningsPositive NewsGap Up1.58%MYGNMyriad Genetics$7.56+6.0%4.023 of 5 stars2.19$20.61 172.6%16Upcoming EarningsHigh Trading Volume1.56%QUREuniQure$14.77-1.5%2.2608 of 5 stars2.82$38.80 162.7%11Upcoming EarningsShort Interest ↑Analyst RevisionNews Coverage1.53%RCKTRocket Pharmaceuticals$8.01+1.9%4.7395 of 5 stars2.92$43.00 436.8%12Upcoming Earnings1.32%VIRVir Biotechnology$6.16+1.3%2.6953 of 5 stars2.86$33.57 445.0%7News Coverage1.05%RGNXREGENXBIO$10.40+5.8%4.4848 of 5 stars2.83$31.63 204.1%6Upcoming EarningsNews CoveragePositive News0.90%FLGTFulgent Genetics$20.54+19.1%2.5244 of 5 stars2.00$16.00 -22.1%1Earnings ReportNews CoverageGap UpHigh Trading Volume0.86%VERVVerve Therapeutics$5.19-5.6%3.8379 of 5 stars3.00$25.75 396.1%6Positive News0.72%PACBPacific Biosciences of California$1.13+1.8%3.2999 of 5 stars2.50$2.45 116.8%10Upcoming EarningsNews Coverage0.62%TSVT2seventy bio$5.00+0.4%1.7548 of 5 stars2.29$5.60 12.0%7Short Interest ↑News Coverage0.61%MRVIMaravai LifeSciences$2.07+2.0%4.0495 of 5 stars2.18$6.34 206.5%11Upcoming EarningsOptions Volume0.55%ALLOAllogene Therapeutics$1.70+0.6%3.3477 of 5 stars2.90$9.29 446.4%10Positive News0.53%SANASana Biotechnology$1.89-0.5%1.9529 of 5 stars2.86$10.80 471.4%7Upcoming Earnings0.36%SGMOSangamo Therapeutics$0.73-1.7%1.5831 of 5 stars2.67$5.17 609.4%6Upcoming EarningsNews CoverageGap Up0.32%EDITEditas Medicine$1.64+1.2%4.2855 of 5 stars2.31$6.54 298.7%16Upcoming EarningsAnalyst UpgradeAnalyst RevisionNews Coverage0.17%CRBUCaribou Biosciences$0.88+9.8%2.6161 of 5 stars3.00$9.33 960.6%5Upcoming EarningsAnalyst Revision0.15%LYELLyell Immunopharma$0.46-1.9%3.4074 of 5 stars1.50$1.00 116.8%2Upcoming EarningsNews Coverage This page (NASDAQ:GNOM) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GNOM Stock Free GNOM Stock Alerts